Key result
New-onset atrial fibrillation occurred in 5% to 15% of general non-cardiac critically ill patients and was associated with increased hospital mortality compared to those without atrial fibrillation.
Why the study?
What is the epidemiology, prevention, and treatment of new-onset atrial fibrillation in non-cardiac critically ill patients?
Population
Non-cardiac adult patients with new-onset atrial fibrillation and atrial flutter during ICU stay
Comparison
Various treatments for new-onset AF vs Patients without new-onset AF
Design
Systematic_review
Follow-up
Hospital stay
Authors
Loading...
May warrant closer monitoring in non-cardiac ICU patients; leaves open optimal prevention and treatment strategies pending RCTs.
Systematic Review (n=54,550)
What is the epidemiology, prevention, and treatment of new-onset atrial fibrillation in non-cardiac critically ill patients?
New-onset AF is common (4.5-15%) in non-cardiac critically ill patients and is associated with higher hospital mortality, though high-quality evidence on its management remains limited.
Yoshida et al. (2015) conducted a systematic review in New-onset atrial fibrillation in non-cardiac critical illness (n=54,550). New-onset atrial fibrillation vs. No atrial fibrillation was evaluated on Incidence of new-onset atrial fibrillation and hospital mortality. New-onset atrial fibrillation occurred in 5% to 15% of general non-cardiac critically ill patients and was associated with increased hospital mortality compared to those without atrial fibrillation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: